Skyrizi (risankizumab)

pCPA File Number: 23349

Negotiation Status:

Under consideration for negotiation

Indication(s):

Ulcerative Colitis

Sponsor/Manufacturer:

AbbVie Corporation

CDA-AMC Project Number:

SR0890-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable